Skip to content
DraconiticResearch
Search Sources API
194,164 studies31 sourcesUpdated 43 min ago
Peer-reviewedCC BY 4.0Cancers

Review of Registries, Databases and Biobanks for Surveillance and Research on Mesothelioma

  • Sarita Prabhakaran1
  • Tim Driscoll2
  • Sue Barker3
  • Geza Benke4
  • Fraser Brims5
  • Meredith Bryant6
  • Elizabeth Chalker7
  • Claire Cooke-Yarborough3
  • Jodie Deakes8
  • Justin Harvey3
  • Susan Harden4
  • Ewan Macfarlane4
9 more authors
  • Kathleen Mahorney8
  • Tom Watson3
  • Phillip Wise7
  • Amy Young3
  • Ken Takahashi9,10,11
  • Zivile Useckaite1
  • David Roder12,13
  • Karen Walker-Bone4
  • Sonja Klebe1,14
14 affiliations
  1. 1Department of Anatomical Pathology, College of Medicine and Public Health, Flinders Health and Medical Research Institute, Flinders University, Adelaide, SA 5042, Australia
  2. 2Sydney School of Public Health, University of Sydney, Sydney, NSW 2006, Australia
  3. 3Australian Institute of Health and Welfare, Canberra, ACT 2601, Australia
  4. 4Monash Centre for Occupational and Environmental Health, Monash University, Melbourne, VIC 3004, Australia
  5. 5Curtin Medical School, Curtin University, Bentley, WA 6102, Australia
  6. 6Safe Work Australia, Canberra, ACT 2601, Australia
  7. 7National Centre for Epidemiology and Population Health, Australian National University, Acton, ACT 2600, Australia
  8. 8Asbestos and Silica Safety and Eradication Agency, Sydney, NSW 2001, Australia
  9. 9Asbestos Dust Diseases Research Institute, Concord, NSW 2139, Australia
  10. 10School of Population and Global Health, University of Western Australia, Perth, WA 6009, Australia
  11. 11Department of Environmental Epidemiology of the Institute of Industrial Ecological, University of Occupational and Environmental Health, Kitakyushu City 807-8555, Japan
  12. 12Cancer Epidemiology and Population Health Research Group, Allied Health and Human Performance, University of South Australia, Adelaide, SA 5000, Australia
  13. 13South Australian Health and Medical Research Institute (SAHMRI), Adelaide, SA 5000, Australia
  14. 14Department of Anatomical Pathology, SA Pathology, Flinders Medical Centre, Bedford Park, SA 5042, Australia
Open at sourceDOICite

Abstract

Mesothelioma is considered a signal tumour of asbestos exposure. Many countries have imposed asbestos bans or effectively no longer use asbestos, but a small number continue to import or mine it. Controls are generally much improved, with resulting plateauing or decreasing rates in many countries, but the effect of past exposures and ongoing exposure through in situ asbestos in buildings and environmental sources results in continued cases of mesothelioma globally. Improper disposal of asbestos is also an obstacle to managing and reducing asbestos exposure. Data on mesothelioma are recorded by mesothelioma registries, population-based cancer registries, healthcare databases, biobanks and online epidemiological data sources. Data from the various sources are significantly different and generally not directly comparable. Mesothelioma registries and population-based cancer registries are excellent resources for epidemiological and statistical data but are typically not linked to clinical data or biospecimen collections. Integrating biospecimen collections with linked clinical data creates rich real-world datasets that enhance research quality, enable data-driven discoveries, and support future translational research. The diagnosis of mesothelioma can be challenging, and data recording is not always accurate or complete across centres. Inconsistencies in data can affect epidemiological studies and undermine efforts to improve policies that affect individuals with mesothelioma and prevent further occurrence of mesothelioma. Linkage between mesothelioma registries, cancer registries, biobanks and other health-related databases will benefit researchers and allow access for further research initiatives. Closer collaboration between registries offers benefits for countries that lack diagnostic and healthcare infrastructure. Established mesothelioma registries can serve as valuable models for countries developing national surveillance systems by sharing expertise in case ascertainment, exposure assessment, registry governance and epidemiological methods. This study is a narrative review based on a non-systematic search of the published literature. This review of mesothelioma-related data resources and biospecimen collections serves as a foundation for enhancing collaboration and knowledge sharing in the fight against mesothelioma.

Related

  1. Strengthening stroke registries for trial readiness and research equity in Sub-Saharan Africa
    Benedict Kusi Ampofo, Fred Stephen Sarfo
    Global Health Research and PolicyPeer-reviewedCC BY 4.0Full textEpidemiology & public healthPMC
  2. Bibliometric analysis of VR interventions in cancer research based on multiple databases: mapping research hotspots and developmental trends
    Ruihan Wang, Yujie Zhang, Lidong Fang +1
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  3. Use of an AI metabolomics score to predict cardiovascular risk among patients with Psoriasis in the MGB and UK Biobanks✰
    Christos P. Kotanidis, Art Schuermans, Priyam Choksi +13
    American journal of preventive cardiologyPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  4. Generalizability of proteomic risk prediction across biobanks reveals dependence on phenotype definitions
    S. J. Parsa, Y. H. Jee, M. A. Argentieri +15
    medRxivPreprintCC BYFull textEpidemiology & public healthmedRxiv
  5. Social Inequalities, Geographical Accessibility to Care, and Excess Mortality for Patients With Hematological Malignancies in France: Results From French Cancer Registries
    J. Gardy, X. Troussard, M. Maynadié +17
    Hematological OncologyPeer-reviewedLicence not statedFull textGeneral biologyOncologyHAL

Cite

BibTeXRIS
BibTeX
@article{prabhakaran2026review,
  title = {{Review of Registries, Databases and Biobanks for Surveillance and Research on Mesothelioma}},
  author = {Sarita Prabhakaran and Tim Driscoll and Sue Barker and Geza Benke and Fraser Brims and Meredith Bryant and Elizabeth Chalker and Claire Cooke-Yarborough and Jodie Deakes and Justin Harvey and Susan Harden and Ewan Macfarlane and Kathleen Mahorney and Tom Watson and Phillip Wise and Amy Young and Ken Takahashi and Zivile Useckaite and David Roder and Karen Walker-Bone and Sonja Klebe},
  journal = {Cancers},
  year = {2026},
  month = oct,
  doi = {10.3390/cancers18213441},
  url = {https://www.mdpi.com/2072-6694/18/21/3441},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Review of Registries, Databases and Biobanks for Surveillance and Research on Mesothelioma
AU  - Sarita Prabhakaran
AU  - Tim Driscoll
AU  - Sue Barker
AU  - Geza Benke
AU  - Fraser Brims
AU  - Meredith Bryant
AU  - Elizabeth Chalker
AU  - Claire Cooke-Yarborough
AU  - Jodie Deakes
AU  - Justin Harvey
AU  - Susan Harden
AU  - Ewan Macfarlane
AU  - Kathleen Mahorney
AU  - Tom Watson
AU  - Phillip Wise
AU  - Amy Young
AU  - Ken Takahashi
AU  - Zivile Useckaite
AU  - David Roder
AU  - Karen Walker-Bone
AU  - Sonja Klebe
PY  - 2026
DA  - 2026/10/24
JO  - Cancers
DO  - 10.3390/cancers18213441
UR  - https://www.mdpi.com/2072-6694/18/21/3441
AB  - Mesothelioma is considered a signal tumour of asbestos exposure. Many countries have imposed asbestos bans or effectively no longer use asbestos, but a small number continue to import or mine it. Controls are generally much improved, with resulting plateauing or decreasing rates in many countries, but the effect of past exposures and ongoing exposure through in situ asbestos in buildings and environmental sources results in continued cases of mesothelioma globally. Improper disposal of asbestos is also an obstacle to managing and reducing asbestos exposure. Data on mesothelioma are recorded by mesothelioma registries, population-based cancer registries, healthcare databases, biobanks and online epidemiological data sources. Data from the various sources are significantly different and generally not directly comparable. Mesothelioma registries and population-based cancer registries are excellent resources for epidemiological and statistical data but are typically not linked to clinical data or biospecimen collections. Integrating biospecimen collections with linked clinical data creates rich real-world datasets that enhance research quality, enable data-driven discoveries, and support future translational research. The diagnosis of mesothelioma can be challenging, and data recording is not always accurate or complete across centres. Inconsistencies in data can affect epidemiological studies and undermine efforts to improve policies that affect individuals with mesothelioma and prevent further occurrence of mesothelioma. Linkage between mesothelioma registries, cancer registries, biobanks and other health-related databases will benefit researchers and allow access for further research initiatives. Closer collaboration between registries offers benefits for countries that lack diagnostic and healthcare infrastructure. Established mesothelioma registries can serve as valuable models for countries developing national surveillance systems by sharing expertise in case ascertainment, exposure assessment, registry governance and epidemiological methods. This study is a narrative review based on a non-systematic search of the published literature. This review of mesothelioma-related data resources and biospecimen collections serves as a foundation for enhancing collaboration and knowledge sharing in the fight against mesothelioma.
SN  - 2072-6694
ER  -